@dansfera: The pharmaceutical world is facing a massive shake-up, and two under-the-radar biopharma companies are sitting right in the middle of it. With a major patent cliff looming, these smaller players are becoming prime targets for acquisition. Watch as the industry pivots to AI to accelerate drug discovery, aiming to get more shots on goal before existing patents expire. It’s a race against time, and CROs are the secret weapon keeping the engine running. #biotech #pharma #ai #stockmarket #investing